VIVUS Reports Second Quarter 2009 Financi...(update or revise any forward-looking sta...),Health

    CONTACT:

    VIVUS, Inc.                Investor Relations: The Trout Group
    Timothy E. Morris                              Brian Korb
    Chief Financial Officer                        646-378-2923
    650-934-5200
                               Media Relations:    Pure Communications, Inc.
                                                   Sheryl Seapy
                                                   949-608-0841

                                    VIVUS, Inc.
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                     (in thousands, except per share amounts)

                                   Three Months Ended     Six Months Ended
                                   June 30,   June 30,   June 30,   June 30,
                                     2009       2008       2009       2008
                                 (unaudited)(unaudited)(unaudited)(unaudited)
    Revenue:
       US product, net             $   3,368  $  2,923 $   4,261  $  4,011
       International product             776     1,300     1,069     1,854
       License and other revenue      10,581    21,046    31,627    42,092

          Total revenue               14,725    25,269    36,957    47,957

    Operating expenses:
       Cost of goods sold and
        manufacturing                  2,877     2,929     5,480     5,716
       Research and development       20,258    15,335    40,327    38,706
       Selling, general and
        administrative                 4,555     4,345     9,966     8,597

          Total operating expenses    27,690    22,609    55,773    53,019

    Income (loss) from operations    (12,965)    2,660   (18,816)   (5,062)
'/>"/>
SOURCE  VIVUS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 
Related medicine news :

1. VIVUS Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes
2. Mesa Labs Reports Higher First Quarter Earnings
3. Physician Owned and Operated Hospitals Get Top Rankings From Consumer Reports, but They Remain on the Healthcare Reform Chopping Block
4. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
5. Winner Medical Reports Third Quarter Fiscal 2009 Results
6. Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results
7. DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results
8. Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results
9. Cardiac Science Reports Q2 Revenue; Resumes AED Shipments
10. PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results
11. Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year